Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Patient Preference × Sorafenib × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 51 Carcinoma, Renal Cell 25 Liver Neoplasms 22 Neoplasms 19 Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 16 Kidney Neoplasms 11 Leukemia, Myeloid, Acute 9 Melanoma 8 Glioblastoma 8 Sarcoma 7 Prostatic Neoplasms 7 Neoplasm Metastasis 7 Brain Neoplasms 7 Thyroid Neoplasms 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Gliosarcoma 5 Urinary Bladder Neoplasms 4 Recurrence 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Carcinoma 4 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leiomyosarcoma 3

Interventions

pertuzumab 1 pazopanib 1 Trastuzumab 1 Surgical Procedures, Operative 1 Sunitinib 1 Risk Assessment 1 Radiotherapy 1 Opdualag 1 Nivolumab 1 Injections, Subcutaneous 1 Bandages, Hydrocolloid 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡